FindTrial
Sign In

Expression and significance of microRNA in peripheral blood of neonatal sepsis

Expression and significance of microRNA in peripheral blood of neonatal sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067623
Enrollment
Unknown
Registered
2023-01-13
Start date
2021-07-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal spesis

Interventions

sepsis group :Not involved
non-infected group:Not involved

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The children in the sepsis group met the diagnostic criteria of "Expert Consensus on Diagnosis and Treatment of Neonatal Sepsis (2019 Edition)"; 2)The control group consisted of non-infected neonates, who were required to have no infection-related risk factors before and during delivery, any clinical symptoms of infection, and no abnormality in laboratory-related infection indicators; 3)The subjects or their proxies voluntarily joined the study, signed the informed consent form, had good compliance, and cooperated with the follow-up.

Exclusion criteria

Exclusion criteria: Suspected inherited metabolic diseases, perinatal asphyxia, congenital malformations, chromosomal disorders, premature infants

Design outcomes

Primary

MeasureTime frame
Plasma miRNA levels;Cytokine expression levels;—

Countries

China

Contacts

Public ContactLing Hao

The First Hospital of Hebei Medical University

haoling1226@163.com18633889937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026